Voyager Therapeutics 8-K Report: Key Insights & SEC Compliance Overview

Based on the provided XML section of a financial report, here are the key insights and important information extracted:

1. Entity Information:

• Name: Voyager Therapeutics, Inc.
• CIK: 0001640266
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-37625
• EIN: 46-3003182
• Address: 75 Hayden Avenue, Lexington, MA 02421
• Phone Number: 857-259-5340

2. Filing Type:

• Type: 8-K
• Filing Date: February 11, 2025

3. Stock Information:

• Common Stock Par Value: $0.001
• Ticker Symbol: VYGR
• Exchange: NASDAQ

4. Reporting Context:

• Report Date: As of February 11, 2025
• Measurement Units:
• • Financial reports are expressed in USD.
  • Shares are also referenced as a unit of measure.

5. Key Dates:

• Start Date of Report Period: February 11, 2025
• End Date of Report Period: February 11, 2025

This information is crucial for understanding the company’s compliance with SEC reporting requirements, the nature of its securities, and the specifics of the filing itself.